Quarterly Financial Summary for the Third Quarter of the Fiscal Year Ending December 2026 [Japanese GAAP] (Consolidated)

Overview of Results

Create Medic Co., Ltd. increased own sales driven by expanded sales of a new urology product; however, operating income, ordinary income and net income decreased year-over-year due to a rise in cost of goods sold as a result of yen depreciation, increased expenses in overseas operations, and higher M&A-related costs. Although net sales rose year-over-year, profitability was pressured, indicating a risk of divergence from the initial forecasts. By segment, own sales performed well, overseas sales were affected by certain factors, and OEM remained strong.

Financial Position and Outlook

Total assets stood at 19,831 million yen, and the equity ratio was 81.4% (slight decrease from the previous fiscal year). Treasury stock acquisitions progressed, and treasury stock amounted to 1,687,151 thousand yen. Financial condition is stable, but the consolidated earnings forecast remains unchanged, and the company will monitor domestic and international business conditions. Earnings presentation materials will be released, and forecasts may be revised and announced if necessary.